Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Iliac covered stent, arterial

PMA Number: P160024 · 2025-09-29

ApplicantBard Peripheral Vascular, Inc.
Decision Date2025-09-29
PMA NumberP160024
Product CodePRL
Device ClassClass 3
Medical SpecialtyU
Advisory CommitteeCV

Device Summary

Iliac covered stent, arterial is the device name listed in this FDA 510(k) record. The listed applicant is Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2025-09-29. The device is classified under product code PRL. It was reviewed by the CV advisory panel.

Frequently Asked Questions

What is the Iliac covered stent, arterial?

Iliac covered stent, arterial is a medical device that received FDA 510(k) clearance on 2025-09-29. The listed applicant is Bard Peripheral Vascular, Inc..

When did Iliac covered stent, arterial receive FDA 510(k) clearance?

The clearance date for Iliac covered stent, arterial can be found in the official FDA records.

Who is the listed applicant for Iliac covered stent, arterial?

The FDA 510(k) record lists Bard Peripheral Vascular, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Iliac covered stent, arterial?

The FDA product code for Iliac covered stent, arterial is PRL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑